Sofosbuvir & Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Ledipasvir INN/Ph.Eur. 90 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution)
Showing the single result
